Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

Medicine & Life Sciences

• Directly Observed Therapy 100%
• Patient Navigation 99%
• Pragmatic Clinical Trials 91%
• Hepatitis C 66%
• Pharmaceutical Preparations 26%
• Hepacivirus 20%
• Odds Ratio 17%
• Treatment Adherence and Compliance 12%
• Therapeutics 10%
• Intention 10%
• velpatasvir 9%
• Patient Outcome Assessment 8%
• Sofosbuvir 7%
• Community Health Centers 6%
• Blister 5%
• Random Allocation 5%
• Tablets 4%
• Opioid Analgesics 4%
• Fibrosis 4%
• Research Personnel 3%
• Randomized Controlled Trials 3%
• Technology 3%
• Databases 3%
• Population 2%